KPMD Research, LLC
Patrick S. Weston, MD, MBA brings 20+ years as a principal investigator across more than 100 industry-sponsored and investigator-initiated trials to the intersection of clinical science, litigation support, and pharmaceutical strategy.
Professional Services
KPMD Research operates at the convergence of clinical research, legal defensibility, and pharmaceutical strategy — offering four distinct service lines anchored by Dr. Weston's rare combination of trial experience and advanced business training.
Independent medical examinations, record reviews, and expert testimony for product liability, mass tort, and complex pharmaceutical litigation. Subspecialty focus in MASH, cardiovascular, and metabolic drug safety.
Learn more →Retained by leading expert networks serving institutional investors, hedge funds, and global pharmaceutical firms. Consulting on cardiometabolic drug development, trial design, FDA regulatory strategy, and pipeline valuation.
Learn more →Strategic advisory to pharmaceutical companies and emerging biotechs on indication selection, clinical trial design, regulatory pathway, and medical affairs strategy. Specific expertise in metabolic disease, MASH, and GLP-1 therapeutics.
Learn more →Biostatistics, regulatory writing, and scientific publication support for sponsors, CROs, and academic institutions. Scientific services are provided in association with Calix Sciences, LLC.
Learn more →Therapeutic & Domain Expertise
Dr. Weston's trial portfolio spans the full spectrum of metabolic and cardiovascular medicine, with particular depth in the indications driving today's highest-value litigation and pharmaceutical development.
Trial Sponsors Include
About Dr. Weston
Patrick S. Weston, MD, MBA is a physician-scientist with more than two decades of experience as a principal investigator on industry-sponsored and investigator-initiated clinical trials. His practice spans cardiometabolic disease, hepatology, obesity medicine, and cardiovascular outcomes research.
Dr. Weston holds an MBA from the Kellogg School of Management at Northwestern University and maintains active medical licenses in Florida, Texas, Arizona, and Illinois. His dual training in clinical medicine and business strategy positions him uniquely at the intersection of pharmaceutical development, complex litigation, and institutional investment advisory.
KPMD Research was established to bring that depth of expertise to attorneys, pharmaceutical executives, and institutional clients who require physician-level insight delivered with the precision and reliability their work demands.
Full Biography & CV